» Authors » Matjaz Novak

Matjaz Novak

Explore the profile of Matjaz Novak including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 297
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Novak M, Baebler S, Zegura B, Rotter A, Gajski G, Geric M, et al.
Chemosphere . 2020 Dec; 263:128097. PMID: 33297093
Imatinib mesylate (IM) is an anticancer drug that belongs to tyrosine kinase inhibitors. We report the results of the first investigation of the chronic exposure of zebrafish (Danio rerio) to...
12.
Moller P, Azqueta A, Boutet-Robinet E, Koppen G, Bonassi S, Milic M, et al.
Nat Protoc . 2020 Oct; 15(12):3817-3826. PMID: 33106678
The comet assay is a widely used test for the detection of DNA damage and repair activity. However, there are interlaboratory differences in reported levels of baseline and induced damage...
13.
Gajski G, Zegura B, Ladeira C, Novak M, Sramkova M, Pourrut B, et al.
Mutat Res Rev Mutat Res . 2019 Aug; 781:130-164. PMID: 31416573
The comet assay has become one of the methods of choice for the evaluation and measurement of DNA damage. It is sensitive, quick to perform and relatively affordable for the...
14.
Gajski G, Zegura B, Ladeira C, Pourrut B, Del Bo C, Novak M, et al.
Mutat Res Rev Mutat Res . 2019 May; 779:82-113. PMID: 31097154
The comet assay, also called single cell gel electrophoresis, is a sensitive, rapid and low-cost technique for quantifying and analysing DNA damage and repair at the level of individual cells....
15.
Prevc A, Kranjc S, Cemazar M, Todorovic V, Zegura B, Novak M, et al.
Radiat Res . 2018 Apr; 189(6):644-651. PMID: 29652621
Human papillomavirus (HPV) is an important etiological factor in oropharyngeal squamous cell carcinoma (SCC). Compared to HPV-negative tumors, HPV-positive oropharyngeal SCC has shown a better response to nonsurgical treatments. In...
16.
Novak M, Zegura B, Modic B, Heath E, Filipic M
Sci Total Environ . 2017 May; 601-602:293-300. PMID: 28558277
Anticancer drugs enter aquatic environment predominantly via hospital and municipal wastewater effluents where they may, due to their genotoxic potential, cause adverse environmental effects even at very low doses. In...
17.
Novak M, Zegura B, Nunic J, Gajski G, Geric M, Garaj-Vrhovac V, et al.
Mutat Res Genet Toxicol Environ Mutagen . 2017 Feb; 814:14-21. PMID: 28137363
The selective tyrosine kinase inhibitor imatinib mesylate (IM) is a widely used anticancer drug. Recent studies showing that IM can induce DNA and chromosomal damage in crustaceans and higher plants...
18.
Isidori M, Lavorgna M, Russo C, Kundi M, Zegura B, Novak M, et al.
Environ Pollut . 2016 Nov; 219:275-287. PMID: 27814544
Anticancer drugs are continuously released into hospital and urban wastewaters, where they, most commonly, undergo conventional treatment in wastewater treatment plants (WWTPs). Wastewaters contain complex mixtures of substances including parent...
19.
Novak M, Hercog K, Zegura B
Toxicon . 2016 May; 118:134-40. PMID: 27137670
A neurotoxin β-N-methylamino-L-alanine (L-BMAA) is a non-protein amino acid produced by most cyanobacteria ubiquitously present in aquatic and terrestrial environments. Due to its global presence in surface waters, a widespread...
20.
cesen M, Elersek T, Novak M, Zegura B, Kosjek T, Filipic M, et al.
Environ Pollut . 2016 Jan; 210:192-201. PMID: 26735164
Cyclophosphamide (CP) and ifosfamide (IF) are commonly used cytostatic drugs that repress cell division by interaction with DNA. The present study investigates the ecotoxicity and genotoxicity of CP, IF, their...